NCKSAP: Radiopharmaceuticals, 3rd Edition

Course Overview

This is a self-assessment CME activity in online format consisting of 30 multiple-choice questions. Each question includes an answer rationale and references for further studying. This module will be updated every 3 years. It is designed for practitioners who are performing nuclear imaging studies and want to increase their competence for certification, recertification or general practice improvement.

Target Audience

This activity is designed for nuclear cardiology physicians.

Learner Objectives

Upon completion of this module, learner will be able to:

Discuss pharmacokinetics and pharmacodynamics of different radioactive tracers
Identify key components in the production, preparation of radioactive tracers, detection and management of impurities and contamination
Recognize benefits and limitations of individual radiopharmaceuticals

Overall Goal

The overall goal of this activity is to provide a comprehensive review of nuclear cardiology imaging procedures and best practices and increase physicians’ competence and performance in their ability to improve cardiovascular disease outcomes.

Continuing Education Term of Approval

Release Date: December 31, 2021
Expiration Date: December 31, 2024

Summary


Availability:	On-Demand
	Expires on Dec 31, 2024


Cost:	Physician & Scientist: $135.00 International Emerging Markets: $55.00 International Physician & Scientist: $135.00 Trainee: $55.00 Non-Physician (Member): $55.00 Physician (Non-Member): $225.00 Non-Physician (Non-Member): $225.00


Credit Offered:	10 CME Credits 10 MOC Points 10 COP Credits